![Christopher Murray](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christopher Murray
Keine laufenden Positionen mehr
Profil
Christopher K.
Murray worked at ARIAD Pharmaceuticals, Inc. from 2004 to 2017, serving as Vice President-Technical Operations from 2013 to 2017.
Dr. Murray worked at Blueprint Medicines Corp.
from 2017 to 2025, serving as Chief Technical Operations & Quality Officer.
Dr. Murray completed undergraduate studies at Hope College in 1984 and graduate studies at The University of Chicago in 1990.
Aktuelle Nachrichten zu Christopher Murray
Ehemalige bekannte Positionen von Christopher Murray
| Unternehmen | Position | Ende |
|---|---|---|
| BLUEPRINT MEDICINES CORPORATION | Technik-/Wissenschafts-/F&E-Leiter | 01.04.2025 |
| ARIAD PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.05.2017 |
Ausbildung von Christopher Murray
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
79
Beziehungen ersten Grades
4
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
ARIAD Pharmaceuticals, Inc.
 ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes small-molecule drugs for the treatment of cancer | Health Technology |
Hope College
 Hope College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Chicago
 The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Blueprint Medicines Corp.
 Blueprint Medicines Corp. BiotechnologyHealth Technology Develops cancer therapies that harness the growing understanding of the molecular blueprint of cancer | Health Technology |
